Cannabis Use and Outcomes in Black and White Patients With Cancer
Recruiting now
Conditions studied: Cancer
In brief
The goal of the observational study is to learn how black and white patients with solid tumor cancer use cannabis, opioids and tobacco. The investigators are using momentary ecological assessment through a smart phone app and surveys to assess patient-reported pain and other symptoms as to inform clinical practice and guidelines for underrepresented populations.
Key facts
- Study ID
- NCT06037681
- Run by
- State University of New York at Buffalo
- People needed
- 600
- Starts
- 2023-03-30
- Expected to finish
- 2027-03-30
- Last updated by the study team
- 2025-10-30
Who can join
Age: 21 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 21 years or older
- Black or white race
- Solid tumor cancer within 3 years of enrollment
- Cannabis use of at least once a week or non cannabis use for 3 months
- experience pain but spend less than 50% in bed or chair
- Prescribed or take opioid for at least 30 days for pain
- Not pregnant or planning to become pregnant in the next 12 months
- English speaking
You may not qualify if…
- Lymphoma, leukemia, and melanoma
- CBD only use
- Synthetic cannabis use in past 3 months = Prescribed Medically-prescribed synthetic cannabis (e.g., dronabinol [Marinol, Syndros], Epidiolex)
- race other than Black or White
Where it is running
- University at Buffalo — Buffalo, New York, United States (enrolling)
- Thomas Jefferson University — Philadelphia, Pennsylvania, United States (enrolling)
- University of Pennsylvania — Philadelphia, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.